On May 13, 2015, an order regarding the plan of liquidation was filed in the bankruptcy case of New England Compounding Pharmacy, Inc. and its affiliates.
The filing was assigned docket number 1317 and is described on the court’s official docket as follows:
Endorsed Order dated 5/13/2015 Re:  Emergency Motion filed by Creditor Committee Official Committee of Unsecured Creditors to (i) Submit Declarations as Direct Testimony of Declarants and (ii) Excuse Declarants from Attendance at Hearing to Consider Confirmation of 1054 First Amended Joint Chapter 11 Plan of New England Compounding Pharmacy, Inc. GRANTED; HOWEVER, TO BE CONSIDERED, ALL SUCH DECLARATIONS MUST BE FILED ON OR BEFORE MAY 15, 2015 AT 5:00 P.M., PREVAILING TIME. FURTHER, ON OR BEFORE MAY 15, 2015 AT 5:00 P.M., PREVAILING TIME, THE PLAN PROPONENTS SHALL FILE A LIST OF THOSE PERSONS, IF ANY, WHO WILL OFFER LIVE TESTIMONY AT THE CONFIRMATION HEARING. (ag)
New England Compounding Pharmacy, Inc. filed for bankruptcy protection, or had an involuntary bankruptcy petition filed against it, on December 21, 2012. The bankruptcy case is pending before the United States Bankruptcy Court for the District of Massachusetts. The case number for the lead bankruptcy case is 12-19882. The bankruptcy case is currently assigned to United States Bankruptcy Judge Henry Boroff. The law firm of Murtha Cullina LLP is acting as lead bankruptcy counsel to New England Compounding Pharmacy, Inc. in the bankruptcy case.